Home Title Index Topic Index Sources Directory News Releases Sources Calendar

Anavex presents data on neuroprotective evidence for ANAVEX 2-73, lead compound for Alzheimer's disease
Sources News Release

http://www.sources.com/Releases/NR1383.htm

Publisher:  Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot
Date Written:  26/07/2011
Year Published:  2011  
Resource Type:  Article

Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to provide a summary of its second poster presentation at the Alzheimer’s Association International Conference (AAIC) held in Paris, entitled Preclinical development of new tetrahydrofur

Abstract:  Hoboken, NJ – July 26, 2011 -- Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) is pleased to provide a summary of its second poster presentation at the Alzheimer’s Association International Conference (AAIC) held in Paris, entitled “Preclinical development of new tetrahydrofuran derivatives targeting the sigma-1 chaperone protein as neuroprotectants in Alzheimer’s disease.”

Neuroprotective, anti-amnesic, anti-depressive and anti-convulsive effects have previously been described with a ne...
To read the full release go to http://www.sources.com/Releases/NR1383.htm

Topics


Sources-journalists use the sources website to find you


AlterLinks
c/o Sources


© 2023.